In Pandemic Response, Quality Experts Advise Drug Manufacturers Move Products To Local Sites
AstraZeneca emptied its warehouses in January. “We said, OK let us pack everything and get it out in the door,” said Tony Mire-Sluis, head of global quality. The firm is allowing only crucial personnel in plants, or those responsible for running a plant or moving products; all others are working from home.
You may also be interested in...
The Canadian government has issued an interim order authorizing the import and sale of two new diagnostic test kits for COVID-19. Other companies making tests for the virus can apply for authorization under the order.
Consumer health product firms say the coronavirus will have an impact on their results, but it’s too early to estimate the costs. US FDA also hedges its predictions, saying the outbreak could lead to interruptions in country’s drug and medical device supplies. China's health commission has issued six guidelines for diagnosis and treatment, but no conventional antiviral treatment is approved and it's emphasizing traditional Chinese medicines.
Quality Desert: How An Academic Minor In Quality Could Be The Key To Quenching Industry's Thirst For QA Professionals
The medtech industry is facing a quickening problem of older workers retiring, leaving holes to fill in quality departments around the globe. In response, a Medical Device Innovation Consortium (MDIC) "Quality as a Career" workgroup partnered with Pathway for Patient Health to create a Quality Science Education framework that can be used by any university or college in the world free-of-charge. The program, packaged as an academic minor, includes six quality-focused courses for students to complete. Xavier University in Cincinnati, OH, recently became the first school to use the program curriculum.